Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aqua Bio Technology ASA Announces Conversion of Debt


Monday, 10 Dec 2012 10:22am EST 

Aqua Bio Technology ASA (ABT) announced that it has received notification from all lenders who have not already converted their share of the loan that they want to convert their respective shares of the loan into shares of ABT. All lenders have notified the Company that they will convert the loan as of December 31, 2012. Shares issued as a result of the conversion will be issued at a price of NOK 6 per share. As a result of the conversion, the Company expects to issue a total of 1,029,635 new shares. New share capital as a result of the conversion will be NOK 27,574,668 divided into 6,893,667 shares. The shares to be issued as a result of the conversion are expected to be issued and listed on the Oslo Axess in the beginning of January 2013. 

Company Quote

17.2
0.4 +2.38%
22 Jul 2014